Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05354375
What this trial is testing

Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer

Who this might be right for
Immunotherapy
The Affiliated Hospital of Xuzhou Medical University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06617481
What this trial is testing

PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence

Who this might be right for
Prostate Cancer (Post Prostatectomy)
AdventHealth 30
Not applicableNot Yet RecruitingNCT06524219
What this trial is testing

Comparison of Nerve-sparing Techniques in Radical Prostatectomy for Oncological Outcome and Functional Recovery.

Who this might be right for
Prostate Cancer
The First Affiliated Hospital with Nanjing Medical University 150
Early research (Phase 1)UnknownNCT05580107
What this trial is testing

MDPK67b in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Med Discovery SA 15
Not applicableApproved For MarketingNCT04452136
What this trial is testing

Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstatic DiseasesProstate Cancer+2 more
Jeanne Link
Not applicableStudy completedNCT02224911
What this trial is testing

Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 8
Not applicableStudy completedNCT03315260
What this trial is testing

Treatment Satisfaction With Ra-223 in Japan

Who this might be right for
Prostatic Neoplasms
Bayer 85
Not applicableStudy completedNCT05880446
What this trial is testing

PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)

Who this might be right for
Prostate CancerRadiotherapy Side EffectBowel Dysfunction+1 more
Jules Bordet Institute 41
Not applicableUnknownNCT03650946
What this trial is testing

Clinical Application of 68Ga-PSMA PET in Prostate Cancer

Who this might be right for
Prostate Cancer
National Taiwan University Hospital 150
Not applicableStudy completedNCT04596917
What this trial is testing

Music Listening as a Postanesthesia Care Unit (PACU) Nursing Intervention

Who this might be right for
Prostate Cancer
Johns Hopkins University 77
Testing effectiveness (Phase 2)Study completedNCT02507427
What this trial is testing

Monitoring and Mapping of Erectile Nerve During RALP (MMEN Study)

Who this might be right for
Prostate Cancer
Seoul National University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00045227
What this trial is testing

Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT02394223
What this trial is testing

FFOCT for the Diagnosis of Prostate Cancer

Who this might be right for
Patients With PSA Level 4.0 ng/mL
Assistance Publique - Hôpitaux de Paris 91
Early research (Phase 1)Ended earlyNCT02487823
What this trial is testing

Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer

Who this might be right for
Non Castrate Metastatic Prostate Cancer
Institut Paoli-Calmettes 6
Testing effectiveness (Phase 2)Ended earlyNCT03531827
What this trial is testing

Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment

Who this might be right for
Metastatic Castration Resistant Prostate CancerProstate Neoplasms
National Cancer Institute (NCI) 4
Early research (Phase 1)Looking for participantsNCT06067841
What this trial is testing

Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Bristol-Myers Squibb 140
Testing effectiveness (Phase 2)Looking for participantsNCT06480110
What this trial is testing

Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Rigshospitalet, Denmark 30
Testing effectiveness (Phase 2)Study completedNCT02830880
What this trial is testing

FACBC Prostate Therapy Response

Who this might be right for
Prostate Cancer
Emory University 7
Early research (Phase 1)Study completedNCT00644488
What this trial is testing

A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 7
Testing effectiveness (Phase 2)Looking for participantsNCT06568562
What this trial is testing

XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of Utah 32
Next Page